Bristol's Yervoy Gets A Bigger Advisory Committee Cushion

The melanoma drug goes up for review by the Oncologic Drugs Advisory Committee Feb. 9, more than six weeks before the PDUFA date of March 26.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet